"Two years ago, as the 🌎 was still coming to grips with the spread of a new coronavirus, WHO did what only WHO can do – we convened hundreds of scientists from around the world to identify the most urgent priorities in R&D. Among them was the development of vaccines."-@DrTedros
"Tomorrow marks the second anniversary of that first meeting.
It’s incredible to think that within a year of that meeting, the first vaccines were approved, and just two years later, more than 10 billion doses have been administered globally."-@DrTedros
"The development and approval of not one, but several [#COVID19] vaccines, in record time is an extraordinary scientific triumph that sets a new standard."-@DrTedros
"There can be no doubt that vaccines have saved countless lives, are helping to turn the tide on the [#COVID19] pandemic, and are now giving many countries the confidence to relax restrictions."-@DrTedros
"But as you know, this scientific triumph has been marred by vast inequities in access.
More than half the world’s population is now fully vaccinated [against #COVID19]. And yet 84% of the population of Africa is yet to receive a single dose."-@DrTedros
"Much of this inequity has been driven by the fact that globally, vaccine production is concentrated in a few mostly high-income countries."-@DrTedros
"One of the most obvious lessons of the [#COVID19] pandemic, therefore, is the urgent need to increase local production of vaccines, especially in low- and middle-income countries."-@DrTedros
"That’s why, in April last year, WHO issued a call for expressions of interest for establishing a technology transfer hub for mRNA vaccines."-@DrTedros
"And it’s already producing results, with Afrigen’s announcement last week that it has produced its own mRNA vaccine, based on publicly available information about the composition of an existing vaccine."-@DrTedros
"We expect this vaccine to be more suited to the contexts in which it will be used, with fewer storage constraints and at a lower price. @MedsPatentPool will manage the intellectual property, and where necessary issue licences to manufacturers."-@DrTedros
"Once a vaccine has been successfully developed, other manufacturers from around the world will be able to produce the vaccine for national and regional use."-@DrTedros
"I congratulate Afrigen on this achievement, and WHO looks forward to supporting you as you take this [#COVID19] vaccine candidate into clinical trials and beyond."-@DrTedros
"I congratulate #SouthAfrica on its leadership throughout the pandemic – in hosting this mRNA technology transfer hub, in chairing the @ACTAccelerator, and in initiating a resolution at the @wto to temporarily suspend intellectual property rights for #COVID19 products"-@DrTedros
"Indeed, if the owners of mRNA vaccine technologies shared them with the Hub, we could expedite manufacturing, removing the need for large clinical trials, and cutting development and approval time by at least one year."-@DrTedros
"Once again, I congratulate all those involved in bringing the mRNA technology transfer hub to this point, and I look forward to its further development."-@DrTedros
"WHO remains committed to supporting the development of local manufacturing in Africa and around the world, to increase regional health security and as part of our vision for the highest attainable standard of health for all people, in all nations."-@DrTedros
• • •
Missing some Tweet in this thread? You can try to
force a refresh
WHO added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for #COVID19.
To date, six COVID-19 treatments have been prequalified by WHO, including the three presentations of the product prequalified today. More info 👉bit.ly/360TTqR
Tocilizumab given intravenously has been shown in clinical studies to prevent death in certain patients with #COVID19 and reduce patients’ time in hospital.
WHO recommends tocilizumab only for patients diagnosed with severe or critical #COVID19. It should be administered by a healthcare worker in a monitored clinical setting.
WHO’s global mRNA vaccine technology transfer hub in #SouthAfrica is building self-reliance & provides a one stop shop for low- & middle-income countries to benefit from the technology transferred & know-how to produce mRNA vaccines bit.ly/3GEI4TT
#COVID19 has demonstrated the importance of investments in science, technology & innovation.
For most of 2021, limited global vaccine supply led to huge disparities in #COVID19 vaccine access, leaving billions of people – especially in low- & middle-income countries – unprotected
The mRNA hub aim is to develop a training facility where mRNA technology is developed to the scale required for mass production of vaccines; then for that full package of technology to be transferrable to multiple recipients in low- & middle-income countries.
🆕 The latest update for the 11th Revision of the International Classification of Diseases (ICD-11) is now online! #ICD11 is a 'common language' for health professionals to share standardized health information around the world.
Learn more bit.ly/3HIYtZ1
The 11th International Classification of Diseases is now fully digital & multilingual with a new user-friendly format & smart coding to reduce the chance of error.
This update reflects input from over 90 countries & unprecedented involvement of health-care providers.
The #ICD11 update includes:
🔹New chapters on addictive disorders
🔹Updated diagnostic recommendations for mental health conditions & digital documentation of #COVID19 certificates
🔹More specific coding for the location & extent of conditions like cancers & fractures
Women & girls living with female genital mutilation face serious threats to their health & well-being.
These include:
🔴 infections
🔴 bleeding
🔴 psychological trauma
🔴 chronic health conditions that can occur throughout life
🔴 death
Happy 70th anniversary, GISRS! The Global Influenza Surveillance and Response System is celebrating 70 years as a global public health collaboration founded to protect people from the threat of #influenza
#Influenza is a serious global health problem that impacts all countries: every year, there are an estimated 1 billion cases of seasonal influenza causing 3 to 5 million severe cases incl. up to 650,000 influenza-related respiratory deaths globally. bit.ly/3sg4BkJ
The Global Influenza Surveillance and Response System continuously monitors #influenza & other respiratory viruses of public health significance, incl. SARS-CoV2. GISRS is a critical resource for #COVID19 disease surveillance, sequencing & testing.
UPDATED: WHO #COVID19 clinical CARE - Confirm, Assess, Respond, Evaluate - tool to support health care workers visualize the current WHO recommendations for the care of patients with COVID-19.